IP Library › Assignment 035948/0139
Patent Assignment
Reel/Frame 035948/0139

Assignment of Assignor's Interest

Recorded: 2015-07-01 Pages: 6
Assignor
SIGMA-TAU PHARMA LIMITED
Executed: 2015-06-22
Assignee
SIGMA-TAU RARE DISEASE LTD
21 HOLBORN VIADUCT, LONDON, EC1A 2DY, UNITED KINGDOM
Covered Properties (10)
Microcrystals Comprising an Active Substance Having an Affinity for Phospholipids, and at Least One Phospholipid, Process of Preparation
Patent: 4,973,465 →
Application: 07/364,481 →
New Process for Preparing Lipid Microparticles
Patent: 5,100,591 →
Application: 07/582,053 →
Methods of Preparing Low-Toxicity Drug-Lipid Complexes
Patent: 6,406,713 →
Application: 08/430,661 →
Low Toxicity Drug-Lipid Systems
Patent: 5,616,334 →
Application: 08/430,699 →
Method of Treating CD4+ T Cell Lymphopenia in Immuno-Compromised Patients
Patent: 5,728,560 →
Application: 08/663,685 →
Connector Enabling Multiple Sampling of Sealed Environment
Patent: 7,584,675 →
Application: 11/780,292 →
Publication: US 2009/0019954
Adenosine Deaminase Anticancer Therapy
Patent: 8,741,283 →
Application: 12/105,682 →
Publication: US 2009/0047270
Stable Recombinant Adenosine Deaminase
Patent: 8,071,741 →
Application: 12/105,913 →
Publication: US 2009/0047271
Stable Recombinant Adenosine Deaminase
Application: 60/913,009 →
Enzymatic Anticancer Therapy
Application: 60/913,039 →
Related Assignments (21)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignors Interest. Oct 31, 1990
From: LECLEF, BRIGITTE; CERFONTAINE, PATRICK; NICOLAS, JEAN-MARIE; WANTIER, HENRI
To: MEDGENIX GROUP S.A.
Reel/Frame 005501/0453 →
Assignment of Assignor's Interest May 12, 1994
From: CELLTARG S.A. (EX. IRE-CELLTARG S.A.)
To: LIPOSOME COMPANY, INC., THE
Reel/Frame 006984/0170 →
Assignment of Assignor's Interest May 12, 1994
From: MEDGENIX GROUP S.A.
To: LIPOSOME COMPANY, INC., THE
Reel/Frame 006983/0557 →
Assignment of Assignor's Interest Sep 23, 1996
From: SHORR, ROBERT G.L.
To: ENZON, INC.
Reel/Frame 008145/0133 →
Assignment of Assignor's Interest Sep 23, 1996
From: CLARK, MIKE A.
To: ENZON, INC.
Reel/Frame 008145/0135 →
Assignment of Assignor's Interest Nov 25, 1996
From: GODDARD, DAVID H.
To: ENZON, INC.
Reel/Frame 008244/0222 →
Merger Jun 14, 2002
From: LIPOSOME COMPANY, INC., THE
To: ELAN PHARMACEUTICALS, INC.
Reel/Frame 012958/0601 →
Assignment of Assignor's Interest Feb 12, 2003
From: ELAN PHARMACEUTICALS, INC.
To: ENZON, INC.
Reel/Frame 013746/0545 →
Assignment of Assignor's Interest Jul 19, 2007
From: EVANS, ROY L.
To: ENZON PHARMACEUTICALS, INC.
Reel/Frame 019577/0781 →
Assignment of Assignor's Interest Jun 13, 2008
From: FILPULA, DAVID R; SAPRA, PUJA
To: ENZON PHARMACEUTICALS, INC.
Reel/Frame 021093/0804 →
Assignment of Assignor's Interest Jun 16, 2008
From: FILPULA, DAVID R.; YOUNGSTER, STEPHEN K.
To: ENZON PHARMACEUTICALS, INC.
Reel/Frame 021099/0336 →
Change of Name Feb 16, 2010
From: ENZON, INC.
To: ENZON PHARMACEUTICALS, INC.
Reel/Frame 023937/0543 →
Assignment of Assignor's Interest Feb 16, 2010
From: ENZON PHARMACEUTICALS, INC.
To: DEFIANTE FARMACEUTICA, S.A.
Reel/Frame 023937/0530 →
Corrective Assignment to Correct the Applicant's Address Must Be Corrected in the Electronic Patent Assignment System Previously Recorded on Reel 023937 Frame 0533. Assignor(S) Hereby Confirms the Correct Address Is Rua Dos Ferreiros 260, Funchal-Madeira, Portugal, 9000-082. Apr 26, 2010
From: ENZON PHARMACEUTICALS, INC.
To: DEFIANTE FARMACEUTICA, S.A.
Reel/Frame 024286/0076 →
Assignment of Assignor's Interest Jun 28, 2010
From: ENZON PHARMACEUTICALS, INC.
To: DEFIANTE FARMACEUTICA, S.A.
Reel/Frame 024599/0071 →
Assignment of Assignor's Interest Feb 7, 2012
From: DEFIANTE FARMACEUTICA, S.A.
To: SIGMA-TAU RARE DISEASES, S.A.
Reel/Frame 027662/0812 →
Merger Apr 29, 2015
From: SIGMA TAU RARE DISEASES S.A.
To: SIGMA-TAU PHARMA LIMITED
Reel/Frame 035551/0219 →
Merger Jun 30, 2015
From: SIGMA-TAU RARE DISEASES S.A.
To: SIGMA-TAU PHARMA LIMITED
Reel/Frame 036039/0195 →
Change of Name Dec 12, 2016
From: SIGMA-TAU RARE DISEASE LIMITED
To: LEADIANT BIOSCIENCES LIMITED
Reel/Frame 040716/0853 →
Assignment of Assignor's Interest Dec 14, 2020
From: LEADIANT BIOSCIENCES LIMITED
To: UNIKERIS LIMITED
Reel/Frame 054641/0399 →
Change of Address Mar 17, 2021
From: UNIKERIS LIMITED
To: UNIKERIS LIMITED
Reel/Frame 055616/0640 →